tradingkey.logo

Vivos Therapeutics Inc

VVOS
1.550USD
+0.050+3.33%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
12.81MMarktkapitalisierung
VerlustKGV TTM

Vivos Therapeutics Inc

1.550
+0.050+3.33%

mehr Informationen über Vivos Therapeutics Inc Unternehmen

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.

Vivos Therapeutics Inc Informationen

BörsenkürzelVVOS
Name des UnternehmensVivos Therapeutics Inc
IPO-datumDec 11, 2020
CEOHuntsman (R. Kirk)
Anzahl der mitarbeiter109
WertpapierartOrdinary Share
GeschäftsjahresendeDec 11
Addresse7921 Southpark Plaza,
StadtLITTLETON
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl80120
Telefon18669084867
Websitehttps://vivos.com/
BörsenkürzelVVOS
IPO-datumDec 11, 2020
CEOHuntsman (R. Kirk)

Führungskräfte von Vivos Therapeutics Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Bradford K. (Brad) Amman
Mr. Bradford K. (Brad) Amman
Chief Financial Officer
Chief Financial Officer
80.00
--
Mr. R. Kirk Huntsman
Mr. R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Ralph E. Green, DDS
Dr. Ralph E. Green, DDS
Independent Director
Independent Director
--
--
Ms. Anja B. Krammer
Ms. Anja B. Krammer
Independent Director
Independent Director
--
--
Mr. Mark F. Lindsay
Mr. Mark F. Lindsay
Independent Director
Independent Director
--
--
Mr. Leonard J. (Lenny) Sokolow, CPA
Mr. Leonard J. (Lenny) Sokolow, CPA
Independent Director
Independent Director
--
--
Dr. Matthew Thompson, M.D.
Dr. Matthew Thompson, M.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Bradford K. (Brad) Amman
Mr. Bradford K. (Brad) Amman
Chief Financial Officer
Chief Financial Officer
80.00
--
Mr. R. Kirk Huntsman
Mr. R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Ralph E. Green, DDS
Dr. Ralph E. Green, DDS
Independent Director
Independent Director
--
--
Ms. Anja B. Krammer
Ms. Anja B. Krammer
Independent Director
Independent Director
--
--
Mr. Mark F. Lindsay
Mr. Mark F. Lindsay
Independent Director
Independent Director
--
--
Mr. Leonard J. (Lenny) Sokolow, CPA
Mr. Leonard J. (Lenny) Sokolow, CPA
Independent Director
Independent Director
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Sleep testing services
2.56M
37.74%
Appliance sales to integrated providers
1.41M
20.71%
Center revenue
790.00K
11.65%
Sponsorship/seminar
236.00K
3.48%
Myofunctional therapy services
205.00K
3.02%
Andere
1.59M
23.40%
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Sleep testing services
2.56M
37.74%
Appliance sales to integrated providers
1.41M
20.71%
Center revenue
790.00K
11.65%
Sponsorship/seminar
236.00K
3.48%
Myofunctional therapy services
205.00K
3.02%
Andere
1.59M
23.40%

Aktionärsstatistik

Aktualisiert: Sat, Jan 31
Aktualisiert: Sat, Jan 31
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Skaff (Michael C.)
8.77%
Luo (Dawei)
6.06%
V-CO Investors, L.L.C.
5.45%
The Vanguard Group, Inc.
3.22%
Armistice Capital LLC
2.65%
Andere
73.84%
Aktionäre
Aktionäre
Anteil
Skaff (Michael C.)
8.77%
Luo (Dawei)
6.06%
V-CO Investors, L.L.C.
5.45%
The Vanguard Group, Inc.
3.22%
Armistice Capital LLC
2.65%
Andere
73.84%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
15.61%
Corporation
7.87%
Investment Advisor
6.66%
Hedge Fund
5.22%
Investment Advisor/Hedge Fund
0.97%
Venture Capital
0.88%
Andere
62.79%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
48
1.30M
13.73%
+499.75K
2025Q3
53
815.76K
10.87%
-21.74K
2025Q2
60
2.22M
33.10%
+944.35K
2025Q1
65
1.44M
22.49%
+733.38K
2024Q4
63
1.28M
22.00%
+869.59K
2024Q3
68
786.28K
18.32%
+305.75K
2024Q2
66
387.48K
12.85%
-179.65K
2024Q1
67
465.07K
19.33%
-62.17K
2023Q4
69
458.43K
25.00%
-105.78K
2023Q3
76
380.33K
31.77%
-57.99K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Skaff (Michael C.)
828.00K
9.21%
+828.00K
--
Jun 09, 2025
Luo (Dawei)
572.02K
6.36%
+572.02K
--
Jul 08, 2025
V-CO Investors, L.L.C.
514.50K
5.72%
--
--
Jun 09, 2025
The Vanguard Group, Inc.
91.46K
1.02%
+48.83K
+114.53%
Sep 30, 2025
Armistice Capital LLC
250.28K
2.78%
+250.28K
--
Sep 30, 2024
Intracoastal Capital, L.L.C.
228.61K
2.54%
+228.61K
--
Dec 30, 2024
Connective Capital Management, LLC
200.00K
2.23%
+200.00K
--
Sep 30, 2025
Strategic Wealth Investment Group, LLC
100.00K
1.11%
+100.00K
--
Sep 30, 2025
Ionic Ventures LLC
83.00K
0.92%
+83.00K
--
Sep 30, 2024
Huntsman (Ronald Kirk)
73.06K
0.81%
--
--
Sep 08, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
DFA Dimensional US Sustainability Core 1 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Oct 26, 2023
Merger
25→1
Oct 26, 2023
Merger
25→1
Oct 26, 2023
Merger
25→1
Oct 26, 2023
Merger
25→1
Datum
Ex-Dividendentag
Art
Verhältnis
Oct 26, 2023
Merger
25→1
Oct 26, 2023
Merger
25→1
Oct 26, 2023
Merger
25→1
Oct 26, 2023
Merger
25→1
KeyAI